Search Orphan Drug Designations and Approvals
-
| Generic Name: | Human monoclonal antibody against platelet-derived growth factor D |
|---|---|
| Date Designated: | 11/02/2004 |
| Orphan Designation: | To slow the progression of IgA nephropathy and delay kidney failure in patients affected by the disease. |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
CuraGen Corporation 322 East Main Street Branford, Connecticut 06405 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







